Project Grant K99EB039097
Award Date 8/5/26
Completion Date 7/31/28
Dollars Obligated $107K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
- The National Institute of Biomedical Imaging and Bioengineering awarded The Johns Hopkins University $621,956 on August 12, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop artificial intelligence algorithms that detect very small pancreatic, hepatobiliary, and upper gastrointestinal cancers in computed tomography scans. The research addresses the late-stage detection problem in these disease categories, which...
- The National Institutes of Health National Cancer Institute awarded Cedars-Sinai Medical Center $1,043,190 on September 12, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop an artificial intelligence model for early-stage pancreatic ductal adenocarcinoma detection in abdominal computed tomography scans. The recipient will develop and enhance an AI tumor detection model focused on small pancreatic tumors through three major enhancements: analyzing CT...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Trustees of Columbia University in the City of New York $845,446 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a scalable artificial intelligence framework for early detection of multiple cancers using electronic health records foundation models. The award funds three principal aims: development of a generalizable...
- The National Cancer Institute (part of the National Institutes of Health under the Department of Health and Human Services) awarded New York University School of Medicine $700,171 on July 16, 2026, to advance deep learning models for clinically significant prostate cancer detection on magnetic resonance imaging. The funded research addresses three specific aims: training a robust deep learning model on diverse imaging datasets to ensure consistent performance across multiple scanners, protocols,...
- The National Institute of Biomedical Imaging and Bioengineering awarded Northwestern University $255,297 on September 15, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop vertical MRI technology for safe imaging of children with cardiac implantable electronic devices. The project addresses a critical clinical gap: infants and children with congenital heart defects who receive epicardial leads—implanted...
- The National Cancer Institute awarded The University of Chicago $249,000 on April 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop explainable artificial intelligence models for predicting early-stage melanoma recurrence through integrative analysis of multiplexed tissue imaging, spatial transcriptomics, and clinical histopathology data. The research addresses the gap between current inadequate prognostic tools and the clinical need to identify...
- The National Institutes of Health National Cancer Institute awarded The Leland Stanford Junior University $660,346 on July 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop multi-vendor artificial intelligence models that assist clinicians in targeting prostate cancer during ultrasound-only biopsies. The project, titled "Real-Time Prostate Cancer Detection on B-Mode Conventional and Micro-Ultrasound for Targeting Clinically Significant Cancer During...
- The National Cancer Institute awarded The Johns Hopkins University $249,000 on January 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop large-scale artificial intelligence using radiomics, deep learning, and physics-based generative modeling to improve clinical outcomes in nuclear medicine. The award funds three specific aims: construction of a large database of clinical positron emission tomography/computed tomography images with physician-annotated...
- The National Cancer Institute awarded the Institute For Systems Biology $555,592 on September 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop AI-driven infrastructure for integrating and analyzing cancer datasets and identifying cancer risk factors. The recipient will construct a multi-modal, harmonized resource for the tumor microenvironment featuring an AI-powered spatial search tool. Using spatial datasets from the Human Tumor Atlas Network (HTAN), the...
- The National Cancer Institute awarded the University of California, Los Angeles $640,956 on May 15, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop an artificial intelligence-enhanced perfusion MRI imaging biomarker for predicting yttrium-90 microsphere distribution in radioembolization treatment of liver cancer. The project addresses the current limitation that determining how Y90 microspheres disperse in a tumor relies on labor-intensive tracking of...